TCM
BMY icon

Teza Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Teza Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,735
Closed -$201K – 81
2025
Q4 		$201K Buy
+3,735
New +$180K 0.65% 72
2024
Q4 		– Sell
-56,826
Closed -$2.94M – 528
2024
Q3 		$2.94M Sell
56,826
-9,241
-14% -$434K 0.32% 81
2024
Q2 		$2.74M Buy
+66,067
New +$2.96M 0.34% 80
2024
Q1 		– Sell
-29,021
Closed -$1.49M – 575
2023
Q4 		$1.49M Buy
29,021
+17,496
+152% +$918K 0.25% 125
2023
Q3 		$669K Sell
11,525
-29,018
-72% -$1.78M 0.11% 263
2023
Q2 		$2.59M Buy
+40,543
New +$2.72M 0.42% 62
2023
Q1 		– Sell
-4,832
Closed -$348K – 517
2022
Q4 		$348K Buy
+4,832
New +$364K 0.07% 413
2022
Q3 		– Sell
-10,774
Closed -$830K – 538
2022
Q2 		$830K Sell
10,774
-19,526
-64% -$1.49M 0.32% 106
2022
Q1 		$2.21M Buy
30,300
+6,413
+27% +$431K 0.83% 18
2021
Q4 		$1.49M Buy
+23,887
New +$1.4M 0.4% 60
2021
Q3 		– Sell
-35,700
Closed -$2.38M – 370
2021
Q2 		$2.38M Sell
35,700
-45,239
-56% -$2.95M 0.39% 78
2021
Q1 		$5.11M Buy
80,939
+73,375
+970% +$4.57M 1.02% 13
2020
Q4 		$469K Sell
7,564
-14,356
-65% -$883K 0.27% 130
2020
Q3 		$1.32M Buy
+21,920
New +$1.32M 0.77% 21
2018
Q4 		– Sell
-21,336
Closed -$1.32M – 341
2018
Q3 		$1.32M Buy
21,336
+2,694
+14% +$160K 0.31% 119
2018
Q2 		$1.03M Buy
18,642
+5,994
+47% +$324K 0.15% 210
2018
Q1 		$800K Sell
12,648
-1,141
-8% -$73.4K 0.19% 211
2017
Q4 		$845K Buy
+13,789
New +$862K 0.51% 37

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Teza Capital Management's BMY Position: Q1 2026 in Review

Teza Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 3,735 shares — an estimated $201K sold.

Teza Capital Management first reported a position in BMY in Q4 2017 and held it in 18 quarters. The position peaked at $5.11M in Q1 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Teza Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Teza Capital Management sold 3,735 Bristol-Myers Squibb shares in Q1 2026, an estimated $201K.
  • Teza Capital Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 18 quarters.
  • Teza Capital Management's Bristol-Myers Squibb position peaked at $5.11M in Q1 2021.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Teza Capital Management's 13F filing for Q1 2026, filed 15 May 2026.